Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease

被引:6
作者
Phelps, Kenneth R. [1 ,2 ]
Mason, Darius L. [1 ,2 ,3 ]
Stote, Kim S. [4 ]
机构
[1] Stratton Vet Affairs Med Ctr, Albany, NY USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[4] SUNY Empire State Coll, Saratoga Springs, NY 12866 USA
关键词
phosphate; phosphorus; chronic kidney disease; parathyroid hormone; fibroblast growth factor 23; DIETARY PHOSPHORUS RESTRICTION; CHRONIC-RENAL-FAILURE; VITAMIN-D; SECONDARY HYPERPARATHYROIDISM; HYPER-PARATHYROIDISM; MINERAL METABOLISM; FGF23; CALCIUM; RATS; CKD;
D O I
10.5414/CN108686
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Increased concentrations of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) often coincide with normal serum phosphorus ([P](s)) in chronic kidney disease (CKD). We hypothesized that the phosphate concentration ([P](f)) in the cortical distal nephron (CDN) determines [PTH] and [FGF23] in this circumstance. Methods: We studied 29 patients with CKD at 4 visits and 28 controls at 1 visit. Assuming GFR = creatinine clearance (C-cr), we examined the following regressions: [P](s) on its determinants, E-P/C-cr and TRP/C-cr (P excretion and reabsorption per volume of filtrate); [PTH] and [FGF23] on [P] s and E-P/C-cr; and TRP/C-cr on [PTH] and [FGF23]. We assumed that E-P/C-cr is proportional to [P](f) in the CDN. Results: In controls, [P](s) correlated with TRP/C-cr but not E-P/C-cr. [PTH] and [FGF23] were unrelated to [P](s), E-P/C-cr, and TRP/C-cr. In CKD, [P](s) correlated with E-P/C-cr and TRP/C-cr. [PTH] correlated with [P](s) at 2 visits and with E-P/C-cr at 4; [FGF23] correlated with [P](s) and E-P/C-cr at all visits. TRP/C-cr correlated with [FGF23] and [PTH] at one visit each. Conclusions: [P](f) in the CDN, not [P](s), determined [PTH] in CKD. Because [FGF23] was consistently associated with only one determinant of [P](s), E-P/C-cr, we infer that [P](f) also determined [FGF23]. In patients with CKD, we speculate that [P](f) in the CDN regulates FGF23 synthesis at that site.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 27 条
[11]   Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD [J].
Isakova, Tamara ;
Barchi-Chung, Allison ;
Enfield, Gwen ;
Smith, Kelsey ;
Vargas, Gabriella ;
Houston, Jessica ;
Xie, Huiliang ;
Wahl, Patricia ;
Schiavenato, Eva ;
Dosch, Austin ;
Gutierrez, Orlando M. ;
Diego, Jorge ;
Lenz, Oliver ;
Contreras, Gabriel ;
Mendez, Armando ;
Weiner, Rory B. ;
Wolf, Myles .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (06) :1009-1018
[12]   Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease [J].
Isakova, Tamara ;
Wahl, Patricia ;
Vargas, Gabriela S. ;
Gutierrez, Orlando M. ;
Scialla, Julia ;
Xie, Huiliang ;
Appleby, Dina ;
Nessel, Lisa ;
Bellovich, Keith ;
Chen, Jing ;
Hamm, Lee ;
Gadegbeku, Crystal ;
Horwitz, Edward ;
Townsend, Raymond R. ;
Anderson, Cheryl A. M. ;
Lash, James P. ;
Hsu, Chi-yuan ;
Leonard, Mary B. ;
Wolf, Myles .
KIDNEY INTERNATIONAL, 2011, 79 (12) :1370-1378
[13]   REVERSAL OF HYPER-PARATHYROIDISM IN RESPONSE TO DIETARY PHOSPHORUS RESTRICTION IN THE UREMIC DOG [J].
KAPLAN, MA ;
CANTERBURY, JM ;
BOURGOIGNIE, JJ ;
VELIZ, G ;
GAVELLAS, G ;
REISS, E ;
BRICKER, NS .
KIDNEY INTERNATIONAL, 1979, 15 (01) :43-48
[14]   NEUTRAL PHOSPHATE ADMINISTRATION GENERATES AND MAINTAINS RENAL METABOLIC ALKALOSIS AND HYPERPARATHYROIDISM [J].
KRAPF, R ;
GLATZ, M ;
HULTER, HN .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 268 (05) :F802-F807
[15]   Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism [J].
Kuro-o, Makoto .
NATURE REVIEWS NEPHROLOGY, 2013, 9 (11) :650-660
[16]  
Lau AH, 1998, INT J ARTIF ORGANS, V21, P19
[17]   Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease [J].
Levin, A. ;
Bakris, G. L. ;
Molitch, M. ;
Smulders, M. ;
Tian, J. ;
Williams, L. A. ;
Andress, D. L. .
KIDNEY INTERNATIONAL, 2007, 71 (01) :31-38
[18]  
Levine BS, 1996, J AM SOC NEPHROL, V7, P488
[19]   Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats [J].
Nagano, N ;
Miyata, S ;
Abe, M ;
Kobayashi, N ;
Wakita, S ;
Yamashita, T ;
Wada, M .
KIDNEY INTERNATIONAL, 2006, 69 (03) :531-537
[20]   Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy? [J].
Oliveira, Rodrigo B. ;
Cancela, Ana L. E. ;
Graciolli, Fabiana G. ;
Dos Reis, Luciene M. ;
Draibe, Sergio A. ;
Cuppari, Lilian ;
Carvalho, Aluizio B. ;
Jorgetti, Vanda ;
Canziani, Maria E. ;
Moyses, Rosa M. A. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (02) :286-291